MIMEDX to Host Second Quarter 2025 Operating and Financial Results Conference Call on July 30GlobeNewsWire • 07/16/25
Strength Seen in MiMedx (MDXG): Can Its 8.0% Jump Turn into More Strength?Zacks Investment Research • 07/09/25
MIMEDX Announces Publication of Health Economics Data in Mohs Micrographic Surgery (MMS)GlobeNewsWire • 05/05/25
MIMEDX to Feature Growing Body of Clinical and Scientific Evidence at Upcoming Wound & Surgical-Focused Industry ConferencesGlobeNewsWire • 04/10/25
MIMEDX Announces Fourth Quarter and Full Year 2024 Operating and Financial ResultsGlobeNewsWire • 02/26/25
MiMedx (MDXG) is on the Move, Here's Why the Trend Could be SustainableZacks Investment Research • 12/18/24
How Much Upside is Left in MiMedx (MDXG)? Wall Street Analysts Think 37.12%Zacks Investment Research • 11/20/24
MiMedx (MDXG) Is a Great Choice for 'Trend' Investors, Here's WhyZacks Investment Research • 11/15/24
MIMEDX's Advocacy to Rein in Runaway Medicare Spend for Skin Substitutes Has Yielded Significant Results with Planned Implementation of LCDsGlobeNewsWire • 11/14/24
Can MiMedx (MDXG) Climb 77.92% to Reach the Level Wall Street Analysts Expect?Zacks Investment Research • 11/04/24
MIMEDX to Host Third Quarter 2024 Operating and Financial Results Conference Call on October 30GlobeNewsWire • 10/14/24
MIMEDX Points to The New York Times Article on the Vast Benefits of Placental TissueGlobeNewsWire • 10/08/24
MIMEDX Showcases Leading Allograft Portfolio and Its Latest Scientific and Clinical Evidence at SAWC FallGlobeNewsWire • 10/01/24